One of those drugs was the anti-inflammatory medication Bextra, which Pfizer pulled off the market in 2005 after it was linked to increasing the risk of heart attacks and strokes.
其中一种药物是抗炎药伐地考昔(Bextra),在发现它可以增加心脏病和中风的危险性之后,辉瑞公司于2005年将其撤市。
The jump wasn't driven by a few high-profile drug problems, such as Merck's withdrawal of painkiller Vioxx in 2004 and Pfizer's suspension of rival painkiller Bextra in 2005.
暴涨不能归因于少数世人瞩目的药物问题,如2004年的默克公司止痛药万络退市和辉瑞公司类似的止痛药Bextra暂停上市。
The jump wasn't driven by a few high-profile drug problems, such as Merck's withdrawal of painkiller Vioxx in 2004 and Pfizer's suspension of rival painkiller Bextra in 2005.
暴涨不能归因于少数世人瞩目的药物问题,如2004年的默克公司止痛药万络退市和辉瑞公司类似的止痛药Bextra暂停上市。
应用推荐